ADAP - Adaptimmune TCR Therapeutics set May 30 for shareholder votes on deal

2023-04-18 16:37:11 ET

• Adaptimmune Therapeutics ( NASDAQ: ADAP ) and TCR Therapeutics ( NASDAQ: TCRR ) have set May 30 for shareholder votes on their planned combination.
• The vote is scheduled for 7:30am EST at the Adaptimmune's ( ADAP ) headquarters in the UK, according to a Form S-4 filing. TCR ( TCRR ) is set to hold a virtual meeting for 8am also on May 30.
• Adaptimmune ( ADAP ) and TCR ( TCRR ) entered into a definitive agreement under which Adaptimmune will combine with TCR in an all-stock transaction last month.

For further details see: